There are 2934 resources available
4648 - Prognostic role of the EANO ESMO classification of leptomeningeal metastases
Presenter: Emilie Le Rhun
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides
4361 - A Phase 0/2 Clinical Trial of a CDK4/6 Inhibitor in Aggressive Meningioma Patients
Presenter: Nader Sanai
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides
Webcast
1688 - Health-related quality of life (HRQoL) evaluation in the REGOMA trial: a randomized, phase II clinical trial analyzing regorafenib activity in relapsed glioblastoma patients
Presenter: Mario Caccese
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides
Webcast
2560 - BAROCCO: A randomized phase II study of weekly paclitaxel vs. cediranib-olaparib combination given with continuous or intermittent schedule in patients with recurrent platinum resistant ovarian cancer (PROC)
Presenter: Nicoletta Colombo
Session: Proffered Paper 1 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
6602 - Phase 1B/2 Study of AVB500 (High Affinity Inhibitor of GAS6/AXL Path) in Combination with PAC and PLD in Platinum Resistant Recurrent Ovarian Cancer
Presenter: Bradley Monk
Session: Proffered Paper 1 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
1547 - Randomized Phase 2 (RP2) Study of ATR inhibitor M6620 in Combination with Gemcitabine versus Gemcitabine alone in Platinum-Resistant High Grade Serous Ovarian Cancer (HGSOC)
Presenter: Panagiotis Konstantinopoulos
Session: Proffered Paper 1 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
6256 - IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1–selected NSCLC
Presenter: David Spigel
Session: Proffered Paper 1 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
3570 - Association between tissue TMB (tTMB) and clinical outcomes with pembrolizumab monotherapy (pembro) in PD-L1-positive advanced NSCLC in the KEYNOTE-010 and -042 trials
Presenter: Roy S. Herbst
Session: Proffered Paper 1 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
4311 - Pembrolizumab (pembro) plus platinum-based chemotherapy (chemo) for metastatic NSCLC: tissue TMB (tTMB) and outcomes in KEYNOTE-021, 189, and 407
Presenter: Luis Paz-Ares
Session: Proffered Paper 1 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
Proffered Paper – CNS tumours - Invited Discussant 392O, 393O and 394O
Presenter: Juan Sepulveda Sanchez
Session: Proffered Paper – CNS tumours
Resources:
Slides
Webcast